Novel biologic agent, lenalidomide, for treating diffuse large B-cell lymphoma

Multiple novel biologic therapies are undergoing investigation for the treatment of non-Hodgkin lymphoma. At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Martin Dreyling (Ludwig-... Author: VJHemOnc Added: 05/05/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts